Insulin Resistance and Adipokines

A tétel rövid nézete
dc.contributor.advisorFülöp, Péter
dc.contributor.advisordeptDepartment of Internal Medicine, Ahu_HU
dc.contributor.authorShastri, Vaishnavi Vijay
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentVároczy, Lászlo
dc.contributor.opponentBácsi, Attila
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Belgyógyászati Intézet::Haematológiai Tanszékhu_HU
dc.contributor.opponentdeptdepartment of immunologyhu_HU
dc.date.accessioned2021-06-17T09:41:33Z
dc.date.available2021-06-17T09:41:33Z
dc.date.created2020-08-17
dc.description.abstractIncreased prevalence of T2DM worldwide has caused this metabolic condition to now reach an epidemic stage. Overweight and more importantly obesity, can result in insulin resistance giving rise to T2DM. T2DM, if untreated can result in severe complications. Adipokines showing potential in treating insulin resistance, are currently a topic of interest in treating insulin resistance induced by obesity.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent31hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/311237
dc.language.isoenhu_HU
dc.subjectAdipokineshu_HU
dc.subjectinsulin signallinghu_HU
dc.subjectleptinhu_HU
dc.subject.dspaceGeneral medicinehu_HU
dc.titleInsulin Resistance and Adipokineshu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)